RECENT NEWS

Registration for the British Society For Microbial Technology’s 41st Annual Microbiology Conference is open now. The event takes place on Thursday 21 May, at North London’s RAF Museum, Hendon.

Una Health has announced a new partnership with Forte Medical to support the distribution of the Peezy urine collection device across the UK, strengthening efforts to improve urine sample quality and diagnostic accuracy within NHS care pathways.

With an ever-increasing demand for faster sterility testing solutions, Alpha Laboratories is pleased to introduce the new RiboNAT rapid sterility test by FUJIFILM Wako.

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage has occurred.

Beckman Coulter Life Sciences and Automata have announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata’s AI-ready automation platform to enable faster, more consistent and more scalable experimentation for research organisations.

En Carta Diagnostics, a Paris-based start-up developing rapid point-of-need molecular diagnostics kits, has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its EC Pocket Lyme.

An NIHR-supported trial is investigating whether a 60-second test could cut the time to diagnose winter respiratory viral infections.

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI), which will focus on metabolic dysfunction-associated steatohepatitis (MASH), supporting more precise disease assessment and clinical decision-making.

Agilent Technologies has announced the launch of the Agilent S540MD Slide Scanner System, a whole-slide imaging (WSI) digital scanner, available for sale in key European markets.

BD (Becton, Dickinson and Company) has announced the global commercial release of BD Research Cloud 7.0, furthering the company's AI roadmap while boosting its position in flow cytometry and life sciences research.

The NHS plans to increase the sensitivity of bowel cancer screening in England as it aims to diagnose cases earlier.

A modern, purpose-built pathology facility is set to replace Scarborough General Hospital’s ageing and increasingly unsafe building, addressing urgent issues caused by reinforced autoclaved aerated concrete (RAAC).

HORIBA has obtained CE IVDR certification for its new Yumizen H500 CRP benchtop haematology analyser which delivers a simultaneous five-part extended differential (DIFF) and rapid C-Reactive Protein (CRP) whole blood measurement.

Drs Stephen Ward (Cell and Gene Therapy Catapult) and Annarita Miccio (Imagine Institute) have been announced the keynote speakers for Cell and Gene Therapy 2026, leading the inaugural two-day event taking place at Hinxton Hall in Cambridge, UK from 9–10 March.

A major UK study has shown that screening children for type 1 diabetes can diagnose the condition in its earliest stages, before symptoms appear.

A major international research project, led by the Global Alzheimer's Platform Foundation, is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer's disease.

The IBMS Awards celebrate the people, teams and organisations making a real impact across biomedical science. From leadership and innovation to education, collaboration and public engagement, the Awards highlight excellence from across the profession.

Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

A new study has confirmed the novel vaccine being used in global efforts to achieve and sustain polio eradication is successfully interrupting polio outbreaks whilst minimising risk of new vaccine-derived outbreaks in Uganda.